NCT04212897

Brief Summary

Functional near-infrared spectroscopy (fNIRS) will be used to monitor neuronal activities and connectivity to elucidate the correlation between physiological changes within the brain and the benefits of music therapy for patients afflicted with Parkinson's disease (PD). This study will report on the changes in neural activities as a result of music intervention in PD.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable parkinson-disease

Timeline
Completed

Started Jan 2021

Shorter than P25 for not_applicable parkinson-disease

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 17, 2019

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 30, 2019

Completed
1.1 years until next milestone

Study Start

First participant enrolled

January 18, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2022

Completed
Last Updated

August 23, 2021

Status Verified

January 1, 2021

Enrollment Period

11 months

First QC Date

December 17, 2019

Last Update Submit

August 20, 2021

Conditions

Keywords

Parkinson DiseaseMusic TherapyfNIRSControlled TrialsExplicit & Implicit TimingMotor ControlSynchronous finger tapping

Outcome Measures

Primary Outcomes (4)

  • Change from Functional Near-infrared Spectroscopy from baseline

    An ETG-4000 fNIRS system will be used to measure hemoglobin (HBO2) levels in the participant as they perform finger motor control timing assessments. A change, specifically a reduction of HBO2 activation, from baseline measurements indicates reduced cortical activation and suggests improved PD-related symptoms.

    Week 0 (baseline), week 4 (during), week 8 (end), and week 12 (follow-up)

  • Change in Synchronous Finger Motor Control Timing Abilities from baseline

    Participants will be asked to tap their right index finger on a standard QWERTY keyboard "1" key when a visual cue appears. The response time for tapping the "1" key, in response to seeing the visual cue, will be measured to assess motor-timing control. Accuracy of response will be dependent on minimizing early or delayed taps (measured in milliseconds) in congruence with the determined rhythm. A change in score, particularly greater accuracy in timing, from baseline indicates better or improved motor control performance.

    Week 0 (baseline), week 4 (during), week 8 (end), and week 12 (follow-up)

  • Change in Continuous Finger Motor Control Timing Abilities from baseline

    Participants will be asked to tap their right index finger on a standard QWERTY keyboard "1" key when a visual cue appears. The participants will then be asked to maintain the tapping rhythm without the visual cue for 15 seconds. The timing of tapping the "1" key, without the visual cue, will be measured to assess motor-timing control. Accuracy of response will be dependent on minimizing early or delayed taps (measured in milliseconds) in congruence with the determined rhythm. A change in score, particularly greater accuracy in timing, from baseline indicates better or improved motor control performance.

    Week 0 (baseline), week 4 (during), week 8 (end), and week 12 (follow-up)

  • Change in Unified Parkinson Disease Rating Scale (UPDRS) from baseline

    UPDRS objectively assesses the severity of PD based off the disease's burden on the individual and can describe disease progression and treatment response. A total of 42 ratings are split between multiple categories. Examples of categories measured include mental impairments (mood and intelligence), activities in daily living (speech, salivation, level of independence to perform normal tasks such as turning in bed), motor skills (facial, tremor severity in extremities, rigidity) and other complications. Each category has a 0-4 rating determined by the examiner and summed, where a higher score reflects greater disability (maxed at 195 points). A change in the score, i.e. lower score from baseline, indicates beneficial effects of the intervention.

    Week 0 (baseline), week 4 (during), week 8 (end), and week 12 (follow-up)

Secondary Outcomes (2)

  • Montreal Cognitive Assessment (MoCA)

    Week 0 (baseline), week 4 (during), week 8 (end), and week 12 (follow-up)

  • n-Back Working Memory Assessment

    Week 0 (baseline), week 4 (during), week 8 (end), and week 12 (follow-up)

Study Arms (2)

Music Therapy

EXPERIMENTAL

This group will be asked to practice a rhythmic auditory SFT intervention task at home.

Other: Music Therapy

No Music Therapy

NO INTERVENTION

This group will not engage in an intervention task at home and will be asked to continue their normal daily routine.

Interventions

Participants in the intervention arm will be asked to practice a rhythmic auditory synchronous finger tapping intervention task at home for a total of 25 minutes split between two ten-minute sets with a five-minute break between the sets every day for 8-weeks. During training sessions participants must listen to the instrumental of a pre-selected well-known Chinese melody, "Moonlight over the Lotus Pond" by Phoenix Legend, whose melody duration is 259s. This song was selected for its strong beat and familiarity to the participants. Participants must follow the beats of the melody and tap their right index finger simultaneously to the beats. A visual cue will be displayed to indicate the beats, identical to the one in the assessment. The training session will be conducted once daily after patients have taken their medication. Participants' primary caretaker will be asked to monitor and record completion of sessions.

Music Therapy

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 40-80 years old, both genders, and right handed;
  • Clinical diagnosis of idiopathic PD according to the 2015 Movement Disorder Society (MDS) Clinical Diagnostic Criteria for Parkinson's Disease;
  • Rated as stage I to II on the Hoehn and Yahr scale;
  • Scores greater than 21 points on the Montreal Cognitive Assessment (MoCA);
  • Maintain a stable dosing of anti-PD or deep-brain stimulation (DBS) treatment throughout the duration of the study;
  • Able to travel to and participate in the data collection process.

You may not qualify if:

  • Presence of significant hearing or visual impairments;
  • Extensive previous musical training;
  • A history of any other neurological condition (i.e. Alzheimer's disease, epilepsy, stroke) or psychiatric disorders (i.e. major depression, psychoses).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

First Affiliated Hospital of Dalian Medical University

Dalian, Liaoning, China

RECRUITING

Related Publications (1)

  • Pu L, Qureshi NK, Ly J, Zhang B, Cong F, Tang WC, Liang Z. Therapeutic benefits of music-based synchronous finger tapping in Parkinson's disease-an fNIRS study protocol for randomized controlled trial in Dalian, China. Trials. 2020 Oct 16;21(1):864. doi: 10.1186/s13063-020-04770-9.

MeSH Terms

Conditions

Parkinson Disease

Interventions

Music Therapy

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Intervention Hierarchy (Ancestors)

Sensory Art TherapiesComplementary TherapiesTherapeuticsRehabilitationAftercareContinuity of Patient CarePatient CarePsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Zhanhua Liang, MD

    The First Affiliated Hospital of Dalian Medical University

    PRINCIPAL INVESTIGATOR
  • Bingwei Zhang, MD

    The First Affiliated Hospital of Dalian Medical University

    PRINCIPAL INVESTIGATOR
  • Fengyu Cong, PhD

    Dalian University of Technology

    PRINCIPAL INVESTIGATOR
  • William C Tang, PhD

    University of California, Irvine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Patients and the outcomes assessor are blinded in this study
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Parallel assignment
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 17, 2019

First Posted

December 30, 2019

Study Start

January 18, 2021

Primary Completion

December 1, 2021

Study Completion

January 1, 2022

Last Updated

August 23, 2021

Record last verified: 2021-01

Data Sharing

IPD Sharing
Will not share

Locations